Cuál es el precio por HLS Therapeutics Inc. (HLS)

Precio por HLS Therapeutics Inc. (HLS) es de$2.75

Cuál es la capitalización de mercado por HLS Therapeutics Inc. (HLS)

Capitalización de mercado por HLS Therapeutics Inc. (HLS) es $86.08M

HLS Therapeutics Inc. (HLS) Rendimiento por Dividendo

HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.

Año	Rendimiento por dividendo	Cambiar
Not enough data for the provided dates.

Año

Rendimiento por dividendo

Cambiar

Not enough data for the provided dates.

Empresa	Rendimiento por dividendo	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	0.83%	IN

Empresa

Rendimiento por dividendo

País